植入药物洗脱支架后出现的晚期支架血栓和自我溶栓病例_第1页
植入药物洗脱支架后出现的晚期支架血栓和自我溶栓病例_第2页
植入药物洗脱支架后出现的晚期支架血栓和自我溶栓病例_第3页
植入药物洗脱支架后出现的晚期支架血栓和自我溶栓病例_第4页
植入药物洗脱支架后出现的晚期支架血栓和自我溶栓病例_第5页
已阅读5页,还剩15页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

A case of very late stent thrombosis and self-thrombolysis after implantation of drug eluting stent 阜外心血管病医院 李崇剑 杨跃进 Case information nMale, 49y. nHT (-), DM (-), Dyslipidemia (-), Smoker (-), FH (-) nAMI (anterior wall) in sep. 2004. nEmergency CAG: ostial LAD 100%, ostial LCX 60%, normal RCA. nEmergency PCI: Cypher in LAD. Detail not acquired. nDrug: (Plavix 75mg/d+ASA 100mg/d)*1y, followed by ASA 75mg/d*qod, other cardio drugs routinely. Case information follow up nAcute chest pain, Re-AMI (anterior) in 6, Nov. 2007. nEmergency CAG: cloud in stent, defect of mid-distal stent, TIMI grade 0. LCX the same as before, normal RCA. nCABG or PCI not performed. nFollowed by drugs: (Plavix 300mg/d+ASA 100mg/d+LWMH 1mg/kg q12h)*12d, other cardio drugs routinely. Angiograhpy (6, Nov. 2007): LAD and LCX Angiograhpy (6, Nov. 2007): RCA Follow up: 2 weeks later nCAG after 2 weeks: no throbosis in stent, LAD TIMI 3. LCX the same as before, normal RCA. Angiography follow up Discussion Thrombosis of DES nDefinition nThe mechanism nStrategy 今 天 讨 论 重 点 DES preventing restenosis after PCI Stent: Vessel Recoil and Remodelling Drug:Intimal Proliferation Dilemma of safety: thrombosis ARC Definition of ST nAcute 0-24h nSubacute 24h-30d nLate 30d-1y nVery late after 1y nDefinite/confirmed nProbable nPossible Time course Angiography and clinical evidence *Antiplatelet Therapy disc Prior Brachy Renal failure Bifurcations ULM Diabetes UA Thrombosis rates according to selected patient characteristics % * Premature discontinuation From A. Colombo, MD Clinical predictors of stent thrombosis 0.01 0.1 1 10 100 0.01 0.1 1 10 100 No thieno* (0-6m) No thieno* (6-18m) LVEF* 30% Prior Brachytherapy RVD* Final atm Stent Length HR=11.7; 95%CI, 3.47-39.24, p0.0001 HR=1.01; 95%CI, 0.30-3.46, p=0.98 HR=4.32; 95%CI, 1.61-11.60, p=0.004 HR=9.89; 95%CI, 3.56-27.46,p0.0001 HR=0.16; 95%CI, 0.03-0.82, p=0.03 HR=0.41; 95%CI, 0.18-0.92, p=0.03 HR=3.41; 95%CI, 1.94-5.97, p0.0001 * * Abbreviations: thieno=thienopyridine; LVEF=left ventricle ejection Abbreviations: thieno=thienopyridine; LVEF=left ventricle ejection fraction; RVD=reference vessel diameterfraction; RVD=reference vessel diameter From A. Colombo, MD DES delayed healing: delayed endothelialization CypherTaxus E F HI 500 m 2 mm 500 m 200 m 500 m 200 m 500 m C 2 mm 200 m J 200 m A BxVelocity 2 mm B D Express L K 2 mm G A. Finn, Renu Virmanin, SOLACI 2006 DES: not only suppress SMC infiltration but also delay endothelialization, leading to stent thrombosis DES Polymer MishapsDES Polymer Mishaps Bonding = polymer sticks to Bonding = polymer sticks to itself forming a bridge when itself forming a bridge when thethe stent stent is expanded is expanded Webbing = polymer pulling away Webbing = polymer pulling away from the expandedfrom the expanded stent stent due to due to stickingsticking Polymer in DES: localized hypersensitivity Virmani, R. et al. Circulation 2004;109:701-705 Late malapposition 基线 正性管腔重构 没有管腔重构 随访 在Taxus和Cypher的研究中,发发生晚 期贴贴壁不良的患者停止clopidogrel治 疗疗后 20% 发生了支架血栓*! * Study by Dr. Abizaid, presented at TCT 2005. 完全闭塞完全闭塞 暴露的支架金属丝暴露的支架金属丝 M, 44y, Cypher due to prior AMI, Clopidegrel was discontinued after 3m, aspirin 150mg/d was continued. 31m later, thrombosis. Eur Heart J. 21 Oct 2005. Case due to late malapposition Discussion: others nManufacturing & Deliverability nHigh pressure, side branch dilatation nInhomogenous drug delivery nThrombogenicity nRestenosis is delayed and but not eliminated nAnd so on. Discussion: strategy n重要的是对LaST形成的研究现状要有清晰的认识,针对可能的发生机制 采取综合措施; n该患者年仅49岁,DES术后坚持1年的双重抗血小板治疗,中止氯吡咯雷 26个月后出现LaST,无合并糖尿病、肾功能不全等病史,虽然未评价血 小板功能,但是推测血栓的形成可能与中止抗血小板治疗及LAD支架操 作有关,也很可能是血管对DES的迟发反应。大多数专家认为双重抗血 小板最少要12个月,至于是否需要更进一步延长还未达成共识,需要更 多的循证医学证据来根据晚期血栓事件的风险对患者进行分层。 n本患者在DES术后38个月发生靶血管AMI,造影提示支架内血栓形成的特 点,其临床过程

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论